Reata Pharmaceuticals, Inc. (RETA) Stock Split, History Data
Working capital analysis
In terms of working capital, Reata Pharmaceuticals, Inc. maintains a healthy position.
The total current assets of the company are valued at $397770000.
This represents a growth rate of -33.313% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $42312000, exhibiting a growth rate of -92.832% year-on-year.
On the liabilities side, the company's current liabilities total $58960000.
This reflects a growth rate of 9.197% over the previous year, indicating the company's financial obligations are well under control.
2022
2021
2020
2019
2018
2017
Cash and investments
42.31
590.26
818.15
664.32
337.79
129.78
Receavebles
0.00
0.00
22.23
0.00
0.00
0.00
Inventory
0.00
0.00
22.23
0.00
0.00
0.00
Other
10.26
6.22
29.19
4.95
4.48
0.00
Total Current Assets
397.77
596.48
847.34
669.28
342.27
133.11
Acc Payable
18.71
13.51
4.79
1.91
4.47
2.07
Short Term Debt
2.15
3.14
87.46
173.77
15.42
1.23
Other Current Liab
38.10
35.70
22.26
11.63
4.70
16.14
Current Liabilities
58.96
53.99
119.20
192.01
55.92
47.62
Capital Structure
When examining the capital structure of Reata Pharmaceuticals, Inc., it is clear that the company manages a robust portfolio.
The value of their total assets clocks in at $502587000.
When juxtaposed with the previous year, this marks a growth rate of -20.420%, showcasing the company's ability to steadily grow its asset base.
Turning to liabilities, the company has total liabilities amounting to $415296000.
Compared to the prior year, this reflects a growth rate of -26.224%.
The long-term debt forms a sizable part of these liabilities, coming in at $163547000.
Over the last year, the long-term debt has grown by 14.760%.
On the asset side, the cash and equivalent reserves are worth $48843000.
The year-on-year growth of these reserves is -66.808%.
The company's common stock, another important asset, holds a value of $38000, growing at a rate of 2.703% from the previous year.
Finally, the company's retained earnings stand at $-1490651000, marking a growth rate of 6.245% year-over-year.
These earnings represent the profits that Reata Pharmaceuticals, Inc. has chosen to reinvest in the business rather than distribute as dividends.
Total Assets
$502.59
Total liabilities
$415,296,000.00
Long term debt
$163.55
Cash and eqv
$48,843,000.00
Goodwill
$0.00
Retained earnings
-$1,490,651,000.00
Common stock
$0.10
Enterprise Value
-$19.39
Net earnings per share (EPS)
Reata Pharmaceuticals, Inc. has an EPS of $2.12, which signifies the profit allocated per share of common stock. With a growth rate of 124.941% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.
